After receiving warning letter by the USFDA, Glenmark Pharmaceuticals responded in the disclosure statement that it is in the process of submitting the corrective and preventive action plan to the ...
Establishing a corrective and preventive action (CAPA) system is a quality system regulation (QSR) requirement for medical device firms marketing products in the United States. Although FDA has always ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback